​Jivo Connect Clinic - Joint Medical Oncology Consultation Drive

​26 March 2026 | 07:30 AM GMT Onwards

​About Jivo Connect Clinic

​Jivo Connect Clinic is a strategic partnership between Jivo and leading Indian hospitals, delivering the expertise of India’s top specialists to African healthcare institutions for complex case management. The model enables structured joint consultations, combining international specialist input with local clinical leadership to enhance patient outcomes.

​International Consulting Specialist

​Dr Niti Krishna Raizada
Principal Director - Medical Oncology & Hemato-Oncology
Fortis Bannerghatta Road, Bengaluru, India

​Supporting Oncology Team:
Dr Prajwal KP - Medical Oncologist
Dr Varsha Bhandarkar - Medical Oncologist

​Dr Raizada brings over 23 years of experience in comprehensive cancer care. Trained at premier institutions including All India Institute of Medical Sciences, Hammersmith Hospital, and Adyar Cancer Institute, she holds MRCP (UK), ECMO certification, an Executive Management Program in Health from the University of Virginia, and Precision Oncology training from Harvard Medical School.

​She leads the oncology centre at Fortis Bannerghatta Road, which delivers over 25,000 chemotherapy, immunotherapy, and biologic treatments annually. Her program integrates systemic oncology, hemato-oncology, stem cell transplantation, and Chimeric Antigen Receptor (CAR) T-cell therapy within a multidisciplinary framework. Dr Raizada has led multinational Phase I to IV clinical trials as Principal Investigator and serves on editorial boards of national and international medical journals.

​Who Should Participate

​This initiative is relevant for:

• ​Medical Oncologists

• ​Haematologists

• ​General Physicians and Internists

• ​General Surgeons

• ​Gynaecologists

• ​Pulmonologists

• ​Paediatricians

• ​Radiologists and Pathologists

​Managing suspected or confirmed cancer and complex blood disorders.

​Suitable Cases

• ​Newly diagnosed cancers requiring treatment planning

• ​Advanced or relapsed malignancies

• ​Chemotherapy and systemic therapy optimisation

• ​Evaluation for stem cell transplantation or CAR T-cell therapy

• ​Second opinions prior to cross-border referral

​Consultation Logistics

• ​Language of consultation: English

• ​For French-speaking participants, an interpreter can be arranged upon prior request

• ​Share patient case notes, imaging, pathology, and relevant reports with your Jivo Coordinator by 24 March, 11:00 PM GMT

​Objective

​To provide systematic case review and high-quality joint consultation, offering patients evidence-based oncology guidance through collaborative specialist engagement.